+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Urological Devices Market Report Suite | Europe | 2019-2025

  • ID: 4877008
  • Report
  • February 2019
  • Region: Europe
  • iData Research
Overall, the urological device market is very well established. This limits the potential for
substantial growth. Although companies continue to provide novel adaptations for their products,
the general trend within the market is a relatively flat ASP. Additionally, the ASP has been limited
by the lack of reimbursement in some countries and price pressures witnessed across Europe.

The full report suite on the European market for urological devices includes devices for benign prostate hyperplasia (BPH), brachytherapy, urinary catheters, nephrostomy, urinary incontinence, stone management, urological endoscopes and erectile dysfunction (ED).
Note: Product cover images may vary from those shown

TABLE OF CONTENTSLIST OF FIGURESLIST OF CHARTS
1. EXECUTIVE SUMMARY
EUROPEAN UROLOGICAL DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
2. DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Urinary System
2.1.1.1 Male Urinary System
2.1.1.2 Female Urinary System
2.2 DISEASE TREATMENT AND DIAGNOSTICS
2.2.1 Benign Prostatic Hyperplasia
2.2.2 Urinary Incontinence
2.2.3 Urinary Tract Infections
2.2.4 Kidney Stones
2.2.5 Bladder Prolapse
2.2.6 Overactive Bladder
2.2.7 Prostatitis
2.2.8 Erectile Dysfunction
2.2.9 Cancer
2.2.9.1 Prostate Cancer
2.2.9.2 Bladder Cancer
2.3 PATIENT DEMOGRAPHICS
2.3.1 Benign Prostatic Hyperplasia
2.3.2 Urinary Incontinence
2.3.3 Urinary Tract Infections
2.3.4 Kidney Stones
2.3.5 Bladder Prolapse
2.3.6 Overactive Bladder
2.3.7 Prostatitis
2.3.8 Erectile Dysfunction
2.3.9 Cancer
2.3.9.1 Prostate Cancer
2.3.9.2 Bladder Cancer
3. PRODUCT ASSESSMENT
3.1 INTRODUCTION
3.2 PRODUCT PORTFOLIOS
3.2.1 Urinary Incontinence
3.2.1.1 Urinary Catheters
3.2.1.1.1 Intermittent Catheters
3.2.1.1.2 Foley Catheters
3.2.1.1.3 Male External Catheters
3.2.1.2 Urethral Bulking Agents
3.2.1.3 Incontinence Management Devices
3.2.1.3.1 Female Incontinence Slings
3.2.1.3.2 Male Implantable Devices
3.2.1.4 Urine Bags
3.2.1.4.1 Leg Bags
3.2.1.4.2 Night Bags
3.2.2 Stone Management
3.2.2.1 ESWL Equipment
3.2.2.2 ISWL Equipment
3.2.2.3 Holmium Lasers
3.2.2.4 Stone Fragment Retrieval Devices
3.2.2.5 Ureteral Stents
3.2.3 BPH Treatment
3.2.3.1 TURP
3.2.3.2 TUMT
3.2.3.3 TUNA
3.2.3.4 Prostatic Stents
3.2.3.5 Laser BPH
3.2.3.5.1 Photoselective Vaporization of the Prostate (PVP)
3.2.3.5.2 Laser Vaporization of the Prostate
3.2.3.5.3 Laser Ablation of the Prostate
3.2.3.5.4 Laser Resection of the Prostate
3.2.3.5.5 Laser Enucleation of the Prostate
3.2.4 Urological Endoscopes
3.2.4.1 Cystoscopes
3.2.4.2 Ureteroscopes
3.2.4.3 Resectoscopes
3.2.4.4 Nephroscopes
3.2.5 Prostate Cancer Treatment
3.2.5.1 Brachytherapy
3.2.5.1.1 Permanent Implants
3.2.5.1.2 Temporary Implants
3.2.5.2 Cryotherapy
3.2.6 Urodynamics
3.2.6.1 Urodynamic Equipment
3.2.6.2 Urodynamic Consumables
3.2.6.2.1 Water-charged Catheters
3.2.6.2.2 Air-charged Catheters
3.2.6.2.3 Fiber Optic Catheters
3.2.7 Nephrostomy
3.2.7.1 Percutaneous Nephrostomy Drainage Tubes & Sets
3.2.7.2 Nephrostomy Balloon Catheters
3.2.7.3 Ureteral Stents
3.2.8 Erectile Dysfunction
3.2.8.1 Penile Implants
3.2.8.1.1 Inflatable
3.2.8.1.2 Malleable
3.2.8.2 Vacuum
3.3 REGULATORY ISSUES AND RECALLS
3.3.1 Boston Scientific
3.3.1.1 Stone Management
3.3.1.2 Nephrostomy
3.3.2 C. R. Bard (Becton Dickinson)
3.3.2.1 Urinary Incontinence
3.3.2.2 Stone Management
3.3.2.3 Urological Endoscopes
3.3.2.4 Prostate Cancer Treatment
3.3.2.5 Nephrostomy
3.3.3 Coloplast
3.3.3.1 Urinary Catheter
3.3.3.2 Erectile Dysfunction
3.3.4 Cook Medical
3.3.4.1 Stone Management
3.3.4.2 Nephrostomy
3.3.5 Elekta
3.3.5.1 Prostate Cancer Treatment
3.3.6 Karl Storz
3.3.6.1 Urological Endoscopes
3.3.7 Olympus
3.3.7.1 Urological Endoscopes
3.4 CLINICAL TRIALS
3.4.1 Boston Scientific
3.4.1.1 Urinary Incontinence
3.4.1.2 BPH Treatment
3.4.1.3 Urological endoscopes
3.4.1.4 Nephrostomy
3.4.1.5 Erectile Dysfunction
3.4.2 C. R. Bard (Becton Dickinson)
3.4.2.1 Urinary Incontinence
3.4.2.2 Prostate Cancer Treatment
3.4.3 Coloplast
3.4.3.1 Urinary Incontinence
3.4.4 Cook Medical
3.4.4.1 Nephrostomy
3.4.5 Elekta
3.4.5.1 Prostate Cancer Treatment
3.4.6 Ethicon
3.4.6.1 Urinary Incontinence
3.4.7 Karl Storz
3.4.7.1 Stone Management
3.4.7.2 Urological Endoscopes
3.4.8 Laborie
3.4.8.1 Urodynamics
3.4.9 Medline
3.4.9.1 Urinary Incontinence
3.4.10 Olympus
3.4.10.1 Stone Management
3.4.10.2 BPH Treatment
3.4.10.3 Urological Endoscopes
4. EUROPEAN UROLOGICAL DEVICE MARKET OVERVIEW
4.1 CURRENCY EXCHANGE RATE
4.2 MARKET OVERVIEW
4.3 TREND ANALYSIS BY SEGMENT
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
4.6 MERGERS AND ACQUISITIONS
4.7 COMPANY PROFILES
4.7.1 Boston Scientific
4.7.2 C. R. Bard (Becton Dickinson)
4.7.3 Coloplast
4.7.4 Cook Medical
4.7.5 Elekta
4.7.6 Ethicon
4.7.7 Karl Storz
4.7.8 Laborie
4.7.9 Medline
4.7.10 Olympus
4.8 SWOT ANALYSIS
4.8.1 Boston Scientific
4.8.2 C. R. Bard (Becton Dickinson)
4.8.3 Coloplast
4.8.4 Cook Medical
4.8.5 Elekta
4.8.6 Ethicon
4.8.7 Karl Storz
4.8.8 Laborie
4.8.9 Medline
4.8.10 Olympus
5.
COUNTRY PROFILES
5.1 INTRODUCTION
5.1.1 Population
5.1.2 GDP Per Capita
5.1.3 Price Index
5.2 GERMANY
5.3 FRANCE
5.4 UNITED KINGDOM
5.5 ITALY
5.6 SPAIN
5.7 BENELUX
5.8 SCANDINAVIA
5.9 AUSTRIA
5.10 SWITZERLAND
5.11 PORTUGAL
6. PROCEDURE NUMBERS
6.1 PROCEDURE OVERVIEW
6.2 PROSTATE CANCER TREATMENT PROCEDURES
6.2.1 Open and Laparoscopic Prostatectomy Procedures
6.2.2 Robotic Prostatectomy Procedures
6.2.3 Watchful Waiting Procedures
6.2.4 HIFU Procedures
6.2.5 Brachytherapy Procedures
6.2.6 High Dose Radiation Procedures
6.2.7 External Radiation Therapy (Primary) Procedures
6.2.8 External Radiation Therapy (Secondary) Procedures
6.3 INTERVENTIONAL BPH PROCEDURES
6.3.1 TURP Procedures
6.3.2 Laser BPH Procedures
6.4 STONE MANAGEMENT PROCEDURES
6.4.1 ESWL Procedures
6.4.2 Stone Management Holmium Laser Procedures
6.4.3 PCNL Procedures
6.4.4 Ureteral Stent Placement Procedures
6.5 NEPHROSTOMY PROCEDURES
6.6 URINARY INCONTINENCE PROCEDURES
6.6.1 Male Urinary Incontinence Procedures
6.6.2 Female Urinary Incontinence Procedures
6.7 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES
6.7.1 Inflatable Erectile Dysfunction Device Implant Procedures
6.7.2 Malleable Erectile Dysfunction Device Implant Procedures
7. BPH TREATMENT DEVICE MARKET
7.1 INTRODUCTION
7.1.1 TURP
7.1.2 Laser BPH
7.1.3 Urolift
7.1.4 Rezum®
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Total TURP Device Market
7.3.1.1 TURP Monopolar Electrode Market
7.3.1.2 TURP Bipolar Electrode Market
7.3.2 Total Laser BPH Device Market
7.3.2.1 Laser BPH Capital Equipment Market
7.3.2.2 Laser BPH Fiber Market
7.3.3 UroLift Market
7.3.4 Rezum Market
7.4 DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE MARKET SHARE ANALYSIS
8. BRACHYTHERAPY MARKET
8.1 INTRODUCTION
8.2 MARKET ANALYSIS AND FORECAST
8.3 DRIVERS AND LIMITERS
8.3.1 Market Drivers
8.3.2 Market Limiters
8.4 COMPETITIVE MARKET SHARE ANALYSIS
9. URINARY CATHETER MARKET
9.1 INTRODUCTION
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Total Urinary Catheter Market
9.3.2 Intermittent Urinary Catheter Market
9.3.3 Foley Catheter Market
9.3.4 Male External Catheter Market
9.4 DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE MARKET SHARE ANALYSIS
10. NEPHROSTOMY DEVICE MARKET
10.1 INTRODUCTION
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
10.3.1 Balloon Dilator Market
10.3.2 Nephrostomy Tube Market
10.3.3 Percutaneous Nephrostomy Access Market
10.4 DRIVERS AND LIMITERS
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 COMPETITIVE MARKET SHARE ANALYSIS
11. URINARY INCONTINENCE DEVICE MARKET
11.1 INTRODUCTION
11.2 MARKET OVERVIEW
11.3 MARKET ANALYSIS AND FORECAST
11.3.1 Urethral Bulking Agent Market
11.3.2 Total Incontinence Sling Market
11.3.2.1 Total Female Incontinence Sling Market
11.3.2.1.1 Transvaginal Tape Female Incontinence Sling Market
11.3.2.1.2 Transobturator Tape Female Incontinence Sling Market
11.3.2.1.3 Single-Incision Female Incontinence Sling Market
11.3.2.2 Male Incontinence Sling Market
11.4 DRIVERS AND LIMITERS
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 COMPETITIVE MARKET SHARE ANALYSIS
12. STONE MANAGEMENT DEVICE MARKET
12.1 INTRODUCTION
12.2 MARKET OVERVIEW
12.3 MARKET ANALYSIS AND FORECAST
12.3.1 Extracorporeal Shock Wave Lithotripsy Device Market
12.3.2 Holmium Laser Fiber Market
12.3.3 Total Stone Fragment Retrieval Device Market
12.3.3.1 Nitinol Basket Market
12.3.3.2 Nitinol Grasper Market
12.3.3.3 Stainless Steel Basket Market
12.3.3.4 Stainless Steel Grasper Market
12.3.4 Ureteral Stent Market
12.4 DRIVERS AND LIMITERS
12.4.1 Market Drivers
12.4.2 Market Limiters
12.5 COMPETITIVE MARKET SHARE ANALYSIS
13. UROLOGICAL ENDOSCOPE MARKET
13.1 INTRODUCTION
13.2 MARKET OVERVIEW
13.3 MARKET ANALYSIS AND FORECAST
13.3.1 Total Urological Endoscope Market
13.3.2 Total Cystoscope Market
13.3.2.1 Rigid Cystoscope Market
13.3.2.2 Total Flexible Cystoscope Market
13.3.2.2.1 Flexible Fiber Optic Cystoscope Market
13.3.2.2.2 Flexible Video Cystoscope Market
13.3.3 Total Ureteroscope Market
13.3.3.1 Semi-Rigid Ureteroscope Market
13.3.3.2 Total Flexible Ureteroscope Market
13.3.3.2.1 Flexible Fiber Optic Ureteroscope Market
13.3.3.2.2 Flexible Video Ureteroscope Market
13.3.4 Rigid Resectoscope Market
13.3.5 Rigid Nephroscope Market
13.4 DRIVERS AND LIMITERS
13.4.1 Market Drivers
13.4.2 Market Limiters
13.5 COMPETITIVE MARKET SHARE ANALYSIS
14. ERECTILE DYSFUNCTION DEVICE MARKET
14.1 INTRODUCTION
14.2 MARKET OVERVIEW
14.3 MARKET ANALYSIS AND FORECAST
14.3.1 Total Erectile Dysfunction Device Market
14.3.2 Inflatable Erectile Dysfunction Device Market
14.3.3 Malleable Erectile Dysfunction Device Market
14.4 DRIVERS AND LIMITERS
14.4.1 Market Drivers
14.4.2 Market Limiters
14.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
Note: Product cover images may vary from those shown
  • Ackermann
  • Agency for Medical Innovations (A.M.I.)
  • Allium Group
  • Amecath
  • Angiodynamics
  • Apexmed International
  • Applied Medical
  • Aqlane Medical
  • Argon Medical
  • Aspide
  • B. Braun
  • Bactiguard
  • Best Medical
  • BioDerm
  • Biolitec
  • Bioteq
  • Boston Scientific
  • BARD
  • Caldera Medical
  • Cardinal Health
  • CL Medical
  • Coloplast
  • Contura
  • Convatec
  • Convergent Laser Technologies
  • Cook Medical
  • Cousin Biotech
  • Degania Medical
  • DeRoyal
  • Direx
  • Dornier MedTech
  • DynaMesh
  • Eckert & Ziegler BEBIG
  • EDAP TMS
  • Electro Medical Systems
  • Elekta
  • Envaste Medical
  • Ethicon
  • GE Healthcare (Oncura)
Note: Product cover images may vary from those shown